Atıf İçin Kopyala
Erman M., Abali H., ORAN B., Haznedaroglu I., Canpinar H., KİRAZLI Ş., ...Daha Fazla
ANNALS OF ONCOLOGY, cilt.15, sa.11, ss.1622-1626, 2004 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
15
Sayı:
11
-
Basım Tarihi:
2004
-
Doi Numarası:
10.1093/annonc/mdh437
-
Dergi Adı:
ANNALS OF ONCOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.1622-1626
-
Anahtar Kelimeler:
breast cancer, hemostasis, hypercoagulability, tamoxifen, TFPI, venous thromboembolism, ACTIVATED PROTEIN-C, SYSTEMIC-LUPUS-ERYTHEMATOSUS, COMBINED ORAL-CONTRACEPTIVES, HORMONE REPLACEMENT THERAPY, FACTOR-V-LEIDEN, BREAST-CANCER, ADJUVANT THERAPY, VENOUS THROMBOSIS, ANTITHROMBIN-III, BLOOD-COAGULATION
-
Hacettepe Üniversitesi Adresli:
Evet
Özet
Background: Current understanding of hemostatic systems enables us to better explore the enigmatic pathobiology of tamoxifen (TAM)-induced thrombotic diathesis. We have therefore aimed to assess the hemostatic changes in breast cancer patients receiving TAM on an adjuvant basis.